NJCC Closes $15 Million NMTC Financing to Support ResinTech Expansion and Economic Growth in Camden

NJCC closed a $15 million New Markets Tax Credit financing transaction supporting ResinTech’s approximately $18.6 million Camden facility expansion, including a 34,500-square-foot addition. The project is expected to retain 259 existing jobs, add 100 permanent full-time positions and support about 113 construction jobs; JPMorgan Chase provided an additional $3 million in NMTC allocation, bringing the project’s total allocation to $18 million. Construction is expected to run from October 2026 through October 2027, and the expansion will increase production of water-treatment products, including PFAS-removal solutions.

Analysis

The investment is a small, indirect signal of U.S. capacity building in specialty water treatment—not evidence of a near-term earnings catalyst for JPMorgan Chase. Its NMTC role is unlikely to be financially material to JPM; any investment case based on this transaction should be rejected absent evidence of meaningful recurring tax-credit activity or a broader strategy shift.

For ResinTech and the sector, added domestic ion-exchange capacity could improve lead times and supply resilience as utilities evaluate PFAS treatment. Potential competitive pressure falls on incumbent resin suppliers such as DuPont, Ecolab’s Purolite business, and LANXESS only if ResinTech converts the expansion into competitively priced, qualified supply. The key bottleneck may be customer validation, treatment-system fit, and management of spent media—not factory square footage. PFAS rules and procurement schedules can create demand, but disposal requirements and alternative technologies such as activated carbon can limit adoption.

Near term, the announcement is unlikely to move public-company fundamentals. Over 1–3 months, watch for customer awards, permits, and evidence of committed demand; construction completion is a 2027 milestone, with utilization and revenue contribution further out. The contrarian point: jobs and planned capacity are not equivalent to contracted volume. A delay, weak bookings, or slower utility procurement would undermine the growth thesis.

Key Decisions for Investors

• No trade in JPM on this announcement: the transaction’s earnings significance is unsubstantiated and likely immaterial. Revisit only if JPM discloses broader, recurring exposure to NMTC investing that changes its tax or community-finance economics.
• Put ResinTech and public water-treatment suppliers on a PFAS procurement watchlist rather than buying the theme on this release. Seek named customer awards, order visibility, and commissioning/utilization evidence before assigning value to incremental capacity.
• Monitor PFAS implementation timelines, utility bid activity, and spent-media disposal constraints over the next 1–3 months; these are more decision-useful demand indicators than projected job counts.
• Falsify the capacity-growth thesis if construction slips materially beyond the planned 2027 completion, customer qualification or awards fail to emerge, or utility procurement slows enough to leave new capacity underused.